from Viewsroom:

Viewsroom: India water woes; fintech; Trumponomics

August 12, 2016

Subscribe to the podcast in iTunes

Drought, farmers, poor pricing and bad infrastructure in the world's second-most populous country hinder Prime Minister Narendra Modi's 'Make in India' vision; peer-to-peer lenders try to deal with a downturn; and Donald Trump's economic plan is more pinstripes than blue collar.

from Breakingviews:

Monsanto may be overestimating independence

July 19, 2016

Olaf Storbeck also contributed to this column. The authors are Reuters Breakingviews columnists. The opinions expressed are their own.

from Breakingviews:

Bayer’s Monsanto bid flags conglomerate curse

May 23, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

BASF best leaving Monsanto seeds for the birds

May 19, 2016

The author is a Reuters Breakingviews columnist.  The opinions expressed are his own.

from Breakingviews:

Bayer would risk choking on Monsanto

May 12, 2016

By Olaf Storbeck and Kevin Allison

The authors are Reuters Breakingviews columnists. The opinions expressed are their own.

from Breakingviews:

Dow-DuPont deal would be tough nut for interlopers

March 7, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

ChemChina can reap rewards of new stance on GMOs

February 4, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are her own.

from Breakingviews:

ChemChina’s Syngenta bid is prickly for Monsanto

February 2, 2016

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Glencore can’t delay with $2 bln agri-sale

November 17, 2015

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Syngenta CEO exit opens door to opportunists

October 21, 2015

The departure of Syngenta’s chief executive may open the door to opportunists. The Swiss agrochemical company’s shareholders had grumbled that Mike Mack and his board were too quick to reject a bid from U.S. rival Monsanto. New leadership may be more credible than Mack at cutting costs – if they get the chance.